Iridex Story

IRIX -- USA Stock

USD 7.35 0.05 0.68%

Macroaxis Story

Iridex Cp Asset Turnover is fairly stable at the moment as compared to the past year. Iridex Cp reported Asset Turnover of 0.94 in 2020. Debt to Equity Ratio is likely to rise to 0.26 in 2021, whereas Net Income Per Employee is likely to drop (90 K) in 2021. In this article, we will break down Iridex Cp. We will evaluate if Iridex Cp shares are reasonably priced going into April. Here I will also expose some primary fundamental factors affecting Iridex Cp's services, and outline how it will impact the outlook for investors this year.

Published over two weeks ago

View all stories for Iridex Cp | View All Stories

What are the odds of Iridex Cp to slide in April?

This firm reported the previous year's revenue of 35.8 M. Net Loss for the year was (7.71 M) with profit before overhead, payroll, taxes, and interest of 17.94 M. About 19.0% of the company shares are held by company insiders. Iridex Cp recorded a loss per share of 0.56. The entity last dividend was issued on the 30th of September 2010.

How important is Iridex Cp's Liquidity

Iridex Cp financial leverage refers to using borrowed capital as a funding source to finance Iridex Cp ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Iridex Cp financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Iridex Cp's total debt and its cash.

How Iridex utilizes its cash?

To perform a cash flow analysis of Iridex Cp, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Iridex Cp is receiving and how much cash it distributes out in a given period. The Iridex Cp cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

Iridex Cp Net Cash Flow from Operations is fairly stable at the moment as compared to the past year. Iridex Cp reported Net Cash Flow from Operations of (3.24 Million) in 2020

What did Iridex Cp file with SEC?

The SEC filings are financial statements or other formal documents of Iridex Cp that are regularly submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make SEC filings and fintech professionals rely on these filings for information about companies they are evaluating for investment purposes. Please note, most SEC filings are available online through the SEC's EDGAR database.

Please check here for more information.

Please note, although all public domestic companies are required to submit their filings via EDGAR, not all public companies are available through our service. Also, keep in mind that the actual annual reports to Iridex shareholders may or may not be submitted as SEC does not always require it.

	23rd of March 2021 Unclassified Corporate Event	View
	22nd of March 2021 Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Results of Operations and Financial Condition	View

Iridex Cp exotic insider transaction detected

Legal trades by Iridex Cp insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:

Iridex insider trading alert for general transaction of common stock by Topcon America Corp, the corporate stakeholder, on 1st of April 2021. This event was filed by Iridex Corp with SEC on 2021-04-01. Initial filing of beneficial ownership - SEC Form 3 [view details]

Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Breaking down the case for Iridex Cp

The market capitalization of Iridex Cp is $102.43 Million. 30% of Iridex Cp outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulation than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.

Ownership Breakdown

Retail Investors

33.18%

Insiders

19.17%

Institutions

47.65%

	Retail Investors	33.18
	Insiders	19.17
	Institutions	47.65

Time to opt out of of Iridex Cp?

The semi variance is down to 22.93 as of today.

As of the 21st of March, Iridex Cp retains the Downside Deviation of 5.96, market risk adjusted performance of (12.10), and Risk Adjusted Performance of 0.2363. Iridex Cp technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Iridex Cp, which can be compared to its competitors. Please check out Iridex Cp downside deviation, treynor ratio, as well as the relationship between the Treynor Ratio and expected short fall to decide if Iridex Cp is priced fairly, providing market reflects its last-minute price of 7.37 per share. Given that Iridex Cp has jensen alpha of 2.67, we strongly advise you to confirm Iridex Cp's regular market performance to make sure the company can sustain itself at a future point.

Our Bottom Line On Iridex Cp

While some other companies within the medical devices industry are still a little expensive, even after the recent corrections, Iridex Cp may offer a potential longer-term growth to investors. Taking everything into account, as of the 21st of March 2021, we believe that at this point, Iridex Cp is fairly valued with very low chance of bankruptcy within the next 2 years. Our final buy-hold-sell advice on the company is Cautious Hold.

About Contributor

Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management. View Profile

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Iridex Cp. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2021 Macroaxis LLC